Clinical Observation of Employment of Umbilical Cord Derived Mesenchymal Stem Cell for Juvenile Idiopathic Arthritis Therapy
Juvenile idiopathic arthritis (JIA), known as Juvenile rheumatoid arthritis, is the most common type of arthritis in children aged under 17. It may cause sequelae due to lack of effective treatment. The goal of this study is to explore the therapeutic effect of umbilical cord mesenchymal stem cells...
Saved in:
Main Authors: | Liming Wang, Yu Zhang, Hongtao Li, Jingxin Hong, Xiaobo Chen, Ming Li, Wen Bai, Jiangang Wang, Yongjun Liu, Mingyuan Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2016/9165267 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atherosclerosis in Juvenile Idiopathic Arthritis
by: Ewa Jednacz, et al.
Published: (2012-01-01) -
Tumor Necrosis Factor Receptor 1 Is Required for Human Umbilical Cord–Derived Mesenchymal Stem Cell–Mediated Rheumatoid Arthritis Therapy
by: Guangyang Liu, et al.
Published: (2025-01-01) -
Concurrence of Juvenile Idiopathic Arthritis and Multiple Sclerosis
by: Ben Abdelghani Kaouther, et al.
Published: (2011-01-01) -
Platelet activation markers in juvenile idiopathic arthritis
by: Pandiarajan Vignesh, et al.
Published: (2019-01-01) -
Mineral Oil Aspiration Related Juvenile Idiopathic Arthritis
by: Andrew D. Nelson, et al.
Published: (2015-01-01)